HIV-1 RNA Quantitative RT-PCR with CD3/CD4/CD8 Immune Deficiency Panel (Panel 2) in Dubai, UAE

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 Accredited Processing. HIV-1 RNA quantification with a lower limit of detection of 20 copies/mL.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed physician.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The HIV-1 RNA Quantitative RT-PCR with CD3/CD4/CD8 Immune Deficiency Panel combines viral load monitoring and lymphocyte subset profiling to provide a comprehensive immune status assessment for people living with HIV. This advanced panel aids in treatment optimization, detecting drug resistance signals, and predicting opportunistic infection risk.

Parameter	Our Precision / Method / Speed	Closest Alternative
HIV-1 RNA Quantification	qPCR (TaqMan®), LOD 20 copies/mL, report within 72 hrs	Standard RT-PCR, LOD 40 copies/mL, 5–7 days
Immune Cell Profiling	4-color Flow Cytometry (CD3/CD4/CD8 absolute counts & %) – dual-platform standardization	Single-platform CD4 only count, no CD3/CD8 ratio
Method	FDA-cleared, CE-IVD, ISO 15189 validated	Locally validated, limited external quality assurance
Turnaround	Sample Wed/Sat before 11am → Report Fri/Tue	Variable, often >1 week
Clinical Utility	Comprehensive → guides ART switching, prophylaxis decisions	Basic → limited insight into immune reconstitution

Physician Insight & Safety Protocols

“This combined panel provides a dynamic window into the immune-viral interplay. It is critical that the results are interpreted alongside the patient’s clinical history, current ART regimen, and any recent infections or vaccinations. Never alter antiretroviral therapy based solely on these numbers.”

— Dr. Ajay Singh, General Practitioner, DHA License 36234132

Medication Advisory

Do not discontinue or adjust any prescribed antiretroviral or prophylactic medication without consulting your treating physician. Abrupt changes can lead to viral rebound, drug resistance, and life-threatening immune deterioration.

Exclusion Criteria & Emergency Red Flags

Exclusion Criteria: Active uncontrolled bleeding disorder (e.g., severe hemophilia); known allergy to antiseptic (chlorhexidine); inability to maintain cold chain for plasma separation within 2 hours.
Do NOT refrigerate or freeze whole blood for flow cytometry—transport at 18–22 °C only.
Emergency Red Flags: Seek immediate medical attention if you experience sudden high fever, severe shortness of breath, altered mental status, or signs of opportunistic infection like new skin lesions or persistent diarrhea. These tests are for monitoring and do not replace emergency assessment.
For minors, testing requires informed consent of a legal guardian as per Federal Decree-Law No. 4 of 2016 on Medical Liability.

Patient FAQ & Clinical Guidance

1. What exactly does the HIV-1 RNA quantitative PCR with CD3/CD4/CD8 panel measure?

It measures the number of HIV-1 virus copies per milliliter of plasma and the absolute counts and percentages of T-lymphocyte subsets (CD3+, CD4+, CD8+). This dual evaluation reveals both the viral suppression level and the functional reserve of the immune system.

2. How should I prepare for the blood draw?

Fast for 12 hours before sample collection; only plain water is allowed. The phlebotomist will collect two lavender-top (EDTA) tubes and one green-top (sodium heparin) tube. Plasma must be separated within 2 hours, so inform the team if you have difficult veins.

3. When will I receive my report and can a doctor explain it to me?

Samples collected before 11 AM on Wednesday or Saturday are reported the following Friday or Tuesday, respectively. A DHA-licensed physician will call you to discuss your results, correlate them with your treatment, and guide any necessary follow-up.

UAE Regulatory & Data Privacy Adherence

All test results and personal health information are protected in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Your data is encrypted, access-restricted, and never shared without your explicit consent.

Clinical & Logistical Metadata

Test Name	HIV-1 RNA Quantitative RT-PCR with CD3/CD4/CD8 Immune Deficiency Panel (Panel 2)
Price (AED)	950
Turnaround Time	72 hours (samples collected Wed/Sat before 11am reported Fri/Tue)
Sample Type / Matrix	Peripheral blood – plasma (HIV-1 RNA) + whole blood (flow cytometry CD3/CD4/CD8)
Methodology Used	Real-time RT-PCR (TaqMan®) + 4-color Flow Cytometry
ICD-10-CM Code	B20
LOINC Code	20416-4
DHA Facility License & Laboratory Address	DHA Facility License Number: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| Corporate Lab Branding: DNA Labs UAE